The DOI matches its Crossref record; 89 of the 91 references it cites were found in a registry or an index.
Rodent models for Alzheimer’s disease drug discovery
Open accessAbstract
INTRODUCTION: Alzheimer's disease (AD) is a neurodegenerative disorder characterized by memory loss and personality changes, leading to dementia. Histopathological hallmarks are represented by aggregates of beta-amyloid peptide (Aβ) in senile plaques and deposition of hyperphosphorylated tau protein in neurofibrillary tangles in the brain. Rare forms of early onset familial Alzheimer's disease are due to gene mutations. This has prompted researchers to develop genetically modified animals that could recapitulate the main features of the disease. The use of these models is complemented by non-genetically modified animals. AREAS COVERED: This review summarizes the characteristics of the most used transgenic (Tg) and non-Tg models of AD. The authors have focused on models mainly used in their laboratories including amyloid precursor protein (APP) Tg2576, APP/presenilin 1, 3xAD, single h-Tau, non-Tg mice treated with acute injections of Aβ or tau, and models of physiological aging. EXPERT OPINION: Animal models of disease might be very useful for studying the pathophysiology of the disease and for testing new therapeutics in preclinical studies but they do not reproduce the entire clinical features of human AD. When selecting a model, researchers should consider the various factors that might influence the phenotype. They should also consider the timing of testing/treating animals since the age at which each model develops certain aspects of the AD pathology varies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Meanwhile, being entirely derived from human cells, these organoids can fully replicate human biology and potentially reduce the translational barriers from experimental findings to therapeutic applications (20–22), offering advantages over animal models (23–25).”
From Understanding monocyte-driven neuroinflammation in Alzheimer’s disease using human cortical organoid microphysiological systems (2025) · cites this paper as [23]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 1×
“Neuronal loss, potentially due to intraneuronal Ab accumulation [59], has been found in a 5XTg mouse model containing APP (Swedish K670N/M671L, Florida I716V, and London V717I) and PSEN1 (M146L and L286V) mutations.”
BackgroundAlzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Pérez‐Tur, J., Hutton, M., Buée, L., Harigaya, Y., Yager, D., et al. (1996) · Nature · doi:10.1038/383710a0 · Cited by 1,486
Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80230-5 · Cited by 1,478
Holcomb, L., Gordon, M. N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., Wright, K., Saad, I., Mueller, R., Morgan, D., et al. (1998) · Nature Medicine · doi:10.1038/nm0198-097 · Cited by 1,386
Billings, L. M., Oddo, S., Green, K. N., McGaugh, J. L., & LaFerla, F. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.040 · Cited by 1,294
Research works printed but not linked: 5
- Alzheimer A, 1906, Neurol Centralblatt, 23, 1129
- 10.1037/0735-7044.113.5.982 · DOI
- Li H, 2015, Neurobiol Aging
- Moe JG, 2008, Evaluation of the effect of extracellular tau oligomers on synaptic function
- Moe JG, 2010, Validation of extracellular tau oligomer target for drug discovery in a novel animal model
Cited by
Sorted by citations
Induced pluripotent stem cell technology: a decade of progress.
Shi, Y., Inoue, H., Wu, J. C., & Yamanaka, S. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.245 · Cited by 1,525
Alzheimer's disease: experimental models and reality
Drummond, E., & Wisniewski, T. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1662-x · Cited by 810
APP mouse models for Alzheimer’s disease preclinical studies.
Sasaguri, H., Nilsson, P., Hashimoto, S., Nagata, K., Saito, T., De Strooper, B., Hardy, J., Vassar, R., Winblad, B., & Saido, T. C. (2017) · The EMBO Journal · doi:10.15252/embj.201797397 · Cited by 793
Temporal and regional progression of Alzheimer’s disease‐like pathology in 3xTg‐AD mice
Belfiore, R., Rodin, A., Ferreira, E., Velazquez, R., Branca, C., Caccamo, A., & Oddo, S. (2019) · Aging Cell · doi:10.1111/acel.12873 · Cited by 332
Role of Amyloid-β and Tau Proteins in Alzheimer’s Disease: Confuting the Amyloid Cascade
Gulisano, W., Maugeri, D., Baltrons, M. A., Fà, M., Amato, A., Palmeri, A., D’Adamio, L., Grassi, C., Devanand, D. P., Honig, L. S., et al. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179935 · Cited by 313
Self-citationThe amyloid cascade hypothesis: an updated critical review
Kepp, K. P., Robakis, N. K. R. K., Høilund‐Carlsen, P. F., Sensi, S. L., & Vissel, B. (2023) · Brain · doi:10.1093/brain/awad159 · Cited by 315
Fan, S., Zheng, Y., Liu, X., Fang, W., Chen, X., Liao, W., Jing, X., Lei, M., Tao, E., Ma, Q., et al. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1461955 · Cited by 267
Mertens, J., Reid, D. A., Lau, S., Kim, Y., & Gage, F. H. (2018) · Annual Review of Genetics · doi:10.1146/annurev-genet-120417-031534 · Cited by 263
The roles of inflammation and immune mechanisms in Alzheimer's disease
Eldik, L. J. V., Carrillo, M. C., Cole, P. E., Feuerbach, D., Greenberg, B., Hendrix, J. A., Kennedy, M. E., Kozauer, N., Margolin, R. A., Molinuevo, J. L., et al. (2016) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2016.05.001 · Cited by 238
Nakano, M., Kubota, K., Kobayashi, E., Chikenji, T., Saito, Y., Konari, N., & Fujimiya, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-67460-1 · Cited by 229
Cummings, J., Ritter, A., & Zhong, K. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179901 · Cited by 176
Millan, M. J. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.03.004 · Cited by 151
Abolhassani, N., Leon, J., Sheng, Z., Oka, S., Hamasaki, H., Iwaki, T., & Nakabeppu, Y. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.05.005 · Cited by 140
Alzheimer’s disease due to loss of function: A new synthesis of the available data
Kepp, K. P. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.06.004 · Cited by 123
Environmental Factors Promoting Neural Plasticity: Insights from Animal and Human Studies
Mandolesi, L., Gelfo, F., Serra, L., Montuori, S., Polverino, A., Curcio, G., & Sorrentino, G. (2017) · Neural Plasticity · doi:10.1155/2017/7219461 · Cited by 120
The keystone of Alzheimer pathogenesis might be sought in Aβ physiology
Puzzo, D., Gulisano, W., Arancio, O., & Palmeri, A. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.08.039 · Cited by 116
Self-citationStress as risk factor for Alzheimer’s disease
Caruso, A., Nicoletti, F., Mango, D., Saidi, A., Orlando, R., & Scaccianoce, S. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.04.017 · Cited by 101
Yu, N., Huang, Y., Jiang, Y., Zou, L., Liu, X., Liu, S., Chen, F., Luo, J., & Zhu, Y. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/9894037 · Cited by 97
Functional Connectivity of the Brain Across Rodents and Humans
Xu, N., LaGrow, T. J., Anumba, N., Lee, A., Zhang, X., Yousefi, B., Bassil, Y., Clavijo, P. G., Sharghi, V. K., Maltbie, E. A., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.816331 · Cited by 100
Cognitive and emotional alterations in App knock-in mouse models of Aβ amyloidosis
Sakakibara, Y., Sekiya, M., Saito, T., Saido, T. C., & Iijima, K. M. (2018) · BMC Neuroscience · doi:10.1186/s12868-018-0446-8 · Cited by 90
Merlo, S., Spampinato, S. F., & Sortino, M. A. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.05.059 · Cited by 94
Induced pluripotent stem cells for neural drug discovery
Farkhondeh, A., Li, R., Gorshkov, K., Chen, K. G., Might, M., Rodems, S. M., Lo, D. C., & Zheng, W. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.01.007 · Cited by 91
Zhang, L., Fang, Y., Cheng, X., Lian, Y.-J., & Xu, H.-L. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1299-y · Cited by 88
Fischer, A. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.11.039 · Cited by 82
Ten Challenges of the Amyloid Hypothesis of Alzheimer’s Disease
Kepp, K. P. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160550 · Cited by 83
Fakhri, S., Abdian, S., Zarneshan, S. N., Moradi, S. Z., Farzaei, M. H., & Abdollahi, M. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s347187 · Cited by 83
Zatsepina, O. G., Evgen’ev, M. B., & Garbuz, D. G. (2021) · Cells · doi:10.3390/cells10071638 · Cited by 80
Huang, J.-L., Qin, M.-C., Zhou, Y., Xu, Z., Yang, S., Zhang, F., Zhong, J., Liang, M.-K., Chen, B., Zhang, W., et al. (2018) · Aging · doi:10.18632/aging.101387 · Cited by 78
Huang, D., Chen, L., Ji, Q., Xiang, Y., Zhou, Q., Chen, K., Zhang, X., Zou, F., Zhang, X., Zhao, Z., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102990 · Cited by 78
Lau, D. H. W., Paillusson, S., Hartopp, N., Rupawala, H., Mórotz, G. M., Gómez‐Suaga, P., Greig, J., Troakes, C., Noble, W. J., & Miller, C. C. J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105020 · Cited by 76
Neves, A. F., Camargo, C. J., Premer, C., Hare, J. M., Baumel, B. S., & Pinto, M. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113706 · Cited by 77
Potential of Caffeine in Alzheimer’s Disease—A Review of Experimental Studies
Londzin, P., Zamora, M., Kąkol, B., Taborek, A., & Folwarczna, J. (2021) · Nutrients · doi:10.3390/nu13020537 · Cited by 71
Locci, A., Orellana, H., Rodríguez, G., Gottliebson, M., McClarty, B. M., Dominguez, S., Keszycki, R. M., & Dong, H. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113192 · Cited by 70
Sakakibara, Y., Sekiya, M., Saito, T., Saido, T. C., & Iijima, K. M. (2019) · BMC Neuroscience · doi:10.1186/s12868-019-0496-6 · Cited by 65
Genetic Pathways of Aging and Their Relevance in the Dog as a Natural Model of Human Aging
Sándor, S., & Kubinyi, E. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00948 · Cited by 68
The two faces of synaptic failure in AppNL-G-F knock-in mice
Latif‐Hernandez, A., Sabanov, V., Ahmed, T., Craessaerts, K., Saito, T., Saido, T. C., & Balschun, D. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00667-6 · Cited by 68
Morroni, F., Sita, G., Tarozzi, A., Rimondini, R., & Hrelia, P. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.08.002 · Cited by 65
Animal Models of Metabolic Disorders in the Study of Neurodegenerative Diseases: An Overview
Bem, A. F. D., Krolow, R., Farias, H. R., de Rezende, V. L., Gelain, D. P., Moreira, J. C. F., Duarte, J. M. N., & de Oliveira, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.604150 · Cited by 69
The Emerging Role of Altered Cerebellar Synaptic Processing in Alzheimer’s Disease
Hoxha, E., Lippiello, P., Zurlo, F., Balbo, I., Santamaria, R., Tempia, F., & Miniaci, M. C. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00396 · Cited by 58
Luo, L., Yan, T., Yang, L., & Zhao, M. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.05.036 · Cited by 58
Importance of GPCR-Mediated Microglial Activation in Alzheimer’s Disease
Haque, M. E., Kim, I., Jakaria, M., Akther, M., & Choi, D. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00258 · Cited by 55
Kong, F., Wu, T., Dai, J., Zhai, Z., Cai, J., Zhu, Z., Xu, Y., & Sun, T. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1205207 · Cited by 54
Capsaicin Attenuates Amyloid-β-Induced Synapse Loss and Cognitive Impairments in Mice
Chen, L., Huang, Z., Du, Y., Fu, M., Han, H., Wang, Y., & Dong, Z. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-170337 · Cited by 54
Exploring the dual character of metformin in Alzheimer's disease
Ning, P., Luo, A., Mu, X. L., Xu, Y., & Li, T. X. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.108966 · Cited by 51
Chen, C., Lu, J., Peng, W., Mak, S., Yang, Y., Zhu, Z., Wang, S., Hou, J., Zhou, X. J., Xin, W., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.106003 · Cited by 51
Preclinical systematic review of ginsenoside Rg1 for cognitive impairment in Alzheimer’s disease
Liang, H.-Y., Zhang, P., Zhang, X., Zheng, Y., Huang, Y., Zheng, G., & Lin, Y. (2021) · Aging · doi:10.18632/aging.202619 · Cited by 50
Preclinical models in the study of sex differences
Buoncervello, M., Marconi, M., Carè, A., Piscopo, P., Malorni, W., & Matarrese, P. (2017) · Clinical Science · doi:10.1042/cs20160847 · Cited by 47
Insight into the emerging and common experimental in-vivo models of Alzheimer’s disease
Dhapola, R., Kumari, S., Sharma, P., & HariKrishnaReddy, D. (2023) · Laboratory Animal Research · doi:10.1186/s42826-023-00184-1 · Cited by 53
Investigations into Retinal Pathology in the Early Stages of a Mouse Model of Alzheimer’s Disease
Chidlow, G., Wood, J. P. M., Manavis, J., Finnie, J. W., & Casson, R. J. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160823 · Cited by 43
Neuroprotective effects of exercise in rodent models of memory deficit and Alzheimer's
Jahangiri, Z., Gholamnezhad, Z., & Hosseini, M. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0343-y · Cited by 43
Shepherd, A. L., Tyebji, S., Hannan, A. J., & Burrows, E. L. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0837-1 · Cited by 43
Luo, A., Ning, P., Lu, H., Huang, H., Shen, Q., Zhang, D., Xu, F., Yang, L. J., & Xu, Y. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220180 · Cited by 42
Ettcheto, M., Sánchez‐López, E., Pons, L., Busquets, O., Olloquequi, J., Beas‐Zárate, C., Pallàs, M., García, M. L., Auladell, C., Folch, J., et al. (2017) · Redox Biology · doi:10.1016/j.redox.2017.06.003 · Cited by 39
Gulisano, W., Tropea, M. R., Arancio, O., Palmeri, A., & Puzzo, D. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.06.002 · Cited by 38
Self-citationEngineered extracellular matrices facilitate brain organoids from human pluripotent stem cells
Muñiz, A. J., Topal, T., Brooks, M. D., Sze, A., Kim, D. H., Jordahl, J. H., Nguyen, J. T., Krebsbach, P. H., Savelieff, M. G., Feldman, E. L., et al. (2023) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51820 · Cited by 35
Targeting SUMO-1ylation Contrasts Synaptic Dysfunction in a Mouse Model of Alzheimer’s Disease
Marcelli, S., Ficulle, E., Iannuzzi, F., Kövari, E., Nisticò, R., & Feligioni, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0176-9 · Cited by 38
Walsh, C., Drinkenburg, W. H. I. M., & Ahnaou, A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.12.020 · Cited by 37
Artificial intelligence for neurodegenerative experimental models
Marzi, S. J., Schilder, B. M., Nott, A., Frigerio, C. S., Willaime‐Morawek, S., Bucholc, M., Hanger, D. P., James, C. R., Lewis, P. A., Lourida, I., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13479 · Cited by 35
Zong, X., Gu, J., Geng, D., & Gao, D. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105356 · Cited by 35
Mendes, N. D., Fernandes, A., de Almeida, G. M., Santos, L. E., Sellés, M. C., Silva, N. M. L. E., Machado, C. D. M., Horta‐Júnior, J. D. A. C., Louzada, P. R., Felice, F. G. D., et al. (2018) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2018.05.021 · Cited by 35
Status of Metabolomic Measurement for Insights in Alzheimer’s Disease Progression—What Is Missing?
Yin, C., Harms, A. C., Hankemeier, T., Kindt, A. S. D., & de Lange, E. C. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054960 · Cited by 33
Induction of Amyloid-β 42 Production by Fipronil and Other Pyrazole Insecticides
Cam, M., Durieu, É., Bodin, M., Manousopoulou, A., Koslowski, S., Vasylieva, N., Barnych, B. B., Hammock, B. D., Bohl, B., Koch, P., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170875 · Cited by 31
Leparulo, A., Mahmud, M., Scremin, E., Pozzan, T., Vassanelli, S., & Fasolato, C. (2019) · Cells · doi:10.3390/cells9010054 · Cited by 31
Age related weight loss in female 5xFAD mice from 3 to 12 months of age
Gendron, W. A. C., Fertan, E., Pelletier, S., Roddick, K. M., O’Leary, T. P., Anini, Y., & Brown, R. E. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113214 · Cited by 31
Chen, X., Jiang, S., Wang, R., Bao, X., & Li, Y. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220721 · Cited by 34
Expression of endogenous mouse APP modulates β-amyloid deposition in hAPP-transgenic mice
Steffen, J., Krohn, M., Schwitlick, C., Brüning, T., Paarmann, K., Pietrzik, C. U., Biverstål, H., Jansone, B., Langer, O., & Pahnke, J. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0448-2 · Cited by 31
Aminyavari, S., Zahmatkesh, M., Khodagholi, F., & Sanati, M. (2019) · Peptides · doi:10.1016/j.peptides.2019.170102 · Cited by 31
Wander, C. M., Tseng, J., Song, S., Housseiny, H. A., Tart, D. S., Ajit, A., Shih, Y. I., Lobrovich, R., Song, J., Meeker, R. B., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101255 · Cited by 30
Research Models to Study Ferroptosis’s Impact in Neurodegenerative Diseases
Costa, I. D., Barbosa, D. J., Silva, V., Benfeito, S., Borges, F., Remião, F., & Silva, R. V. D. S. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051369 · Cited by 30
MacLeod, A., Coquelin, K.-S., Huertas, L., Simeons, F. R. C., Riley, J., Casado, P., Guijarro, L., Casanueva, R., Frame, L., Pinto, É. G., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2315069121 · Cited by 29
Nanoscale Structure and Spectroscopic Probing of Aβ1-40 Fibril Bundle Formation
Psonka-Antonczyk, K. M., Hammarström, P., Johansson, L. B. G., Lindgren, M., Stokke, B. T., Nilsson, K. P. R., & Nyström, S. (2016) · Frontiers in Chemistry · doi:10.3389/fchem.2016.00044 · Cited by 29
Ledesma, J. C., Rodríguez‐Arias, M., Gavito, A., Sánchez‐Pérez, A. M., Viña, J., Vera, D. M., de Fonseca, F. R., & Miñarro, J. (2020) · Addiction Biology · doi:10.1111/adb.12883 · Cited by 29
Current Strategies and Novel Drug Approaches for Alzheimer Disease
Ghai, R., Nagarajan, K., Arora, M., Grover, P., Ali, N., & Kapoor, G. T. (2020) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527319666200717091513 · Cited by 29
Dorner‐Ciossek, C., Kroker, K. S., & Rosenbrock, H. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-58811-7_9 · Cited by 29
Vasilopoulou, F., Rodríguez‐Arévalo, S., Bagán, A., Escolano, C., Griñán‐Ferré, C., & Pallàs, M. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15478 · Cited by 29
Ettcheto, M., Abad, S., Petrov, D., Pedrós, I., Busquets, O., Sánchez‐López, E., Casadesús, G., Beas‐Zárate, C., Carro, E., Auladell, C., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0690-4 · Cited by 28
Caneus, J., Akanda, N., Rumsey, J. W., Guo, X., Jackson, M., Long, C. J., Sommerhage, F., Georgieva, S., Kanaan, N. M., Morgan, D., et al. (2020) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12029 · Cited by 29
Influence of Genetic Background on Apathy-Like Behavior in Triple Transgenic AD Mice.
Pardossi-Piquard, R., Lauritzen, I., Bauer, C., Sacco, G., Robert, P., & Checler, F. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160404120106 · Cited by 22
Sharma, A., Menon, P. K., Patnaik, R., Muresanu, D. F., Lafuente, J. V., Tian, Z. R., Ozkızılcık, A., Mössler, H., & Sharma, H. S. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.09.002 · Cited by 27
Ko, E. C., Spitz, S., Pramotton, F. M., Barr, O. M., Xu, C., Pavlou, G., Zhang, S., Tsai, A., Maaser‐Hecker, A., Jorfi, M., et al. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1251195 · Cited by 27
Shepherd, A. L., Zhang, T. D., Zeleznikow-Johnston, A., Hannan, A. J., & Burrows, E. L. (2018) · Brain Plasticity · doi:10.3233/bpl-180076 · Cited by 28
Blood-based systems biology biomarkers for next-generation clinical trials in Alzheimer’s disease
Hampel, H. J., Vergallo, A., Afshar, M., Akman-Anderson, L., Arenas, J., Benda, N., Batrla, R., Broich, K., Caraci, F., Cuello, A. C., et al. (2019) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2019.21.2/hhampel · Cited by 27
Lin, J., Niu, Z., Xue, Y., Gao, J., Zhang, M., Li, M., Peng, Y., Zhang, S., Li, W., Zhang, Q., et al. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136725 · Cited by 26
Giménez‐Llort, L., Marín-Pardo, D., Marazuela, P., & Hernández‐Guillamón, M. (2021) · Biomedicines · doi:10.3390/biomedicines9060636 · Cited by 26
Reutzel, M., Grewal, R., Joppe, A., & Eckert, G. P. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.875989 · Cited by 25
Zhou, F., Jiang, J., Griffith, C. M., Patrylo, P. R., Cai, H., Chu, Y., & Yan, X. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0370-2 · Cited by 25
Boutajangout, A., Lindberg, H., Awwad, A., Paul, A., Baitalmal, R., Almokyad, I. K., Höidén‐Guthenberg, I., Gunneriusson, E., Frejd, F. Y., Härd, T., et al. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00064 · Cited by 25
Shevtsova, E. F., Angelova, P. R., Stelmashchuk, O. A., Esteras, N., Васильева, Н. А., Maltsev, A. V., Shevtsov, P. N., Shaposhnikov, A. V., Фисенко, В. П., Бачурин, С. О., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-16817-9 · Cited by 26
Beyond Transgenic Mice: Emerging Models and Translational Strategies in Alzheimer’s Disease
Lopes, P. A., & Guil‐Guerrero, J. L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125541 · Cited by 23
Giuliani, A., Sivilia, S., Baldassarro, V. A., Gusciglio, M., Lorenzini, L., Sannia, M., Calzà, L., & Giardino, L. (2019) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly125 · Cited by 23
Fertan, E., Wong, A. A., Vienneau, N. A., & Brown, R. E. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.111937 · Cited by 26
Does Diet Have a Role in the Treatment of Alzheimer's Disease?
Thelen, M., & Brown‐Borg, H. M. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.617071 · Cited by 24
Inborn errors of metabolism: Lessons from iPSC models
Escribá, R., Ferrer‐Lorente, R., & Raya, Á. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09671-z · Cited by 22
Alzheimer Combination Therapies: Overview and Scenarios
Cummings, J. L., Burstein, A. H., & Fillit, H. M. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100328 · Cited by 22
Nakabeppu, Y. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-3540-2_3 · Cited by 20
Neurotoxicity of Pyrethroids in neurodegenerative diseases: From animals' models to humans’ studies
Arsuffi-Marcon, R., Souza, L. G., Santos‐Miranda, A., & Joviano‐Santos, J. V. (2024) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2024.110911 · Cited by 20
Memory Enhancers for Alzheimer’s Dementia: Focus on cGMP
Fedele, E., & Ricciarelli, R. (2021) · Pharmaceuticals · doi:10.3390/ph14010061 · Cited by 20
Whisker exploration behaviours in the 5xFAD mouse are affected by sex and retinal degeneration
Grant, R. A., Wong, A. A., Fertan, E., & Brown, R. E. (2018) · Genes Brain & Behavior · doi:10.1111/gbb.12532 · Cited by 19
Tian, S. L., Ye, T., & Cheng, X. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114505 · Cited by 21
Wu, X.-G., Jianjun, C., Cao, Q., Zhang, H., Lukun, Y., & Yazhen, S. (2018) · Journal of Visualized Experiments · doi:10.3791/56157 · Cited by 19
Metadata
- Authors
- Puzzo, D., Gulisano, W., Palmeri, A., & Arancio, O.
- Affiliations
- University of Catania (IT)
- Columbia University (US)
- Venue
- Expert Opinion on Drug Discovery
- Publisher
- Informa UK Limited
- Published
- 2015-04-30
- Volume
- 10
- Issue
- 7
- Pages
- 703-711
- ISSN
- 1746-0441 (ISSN-L)
- 1746-045X
- PMC
- PMC4592281
- OpenAlex
- W1963514255
- Cited by
- 222
- References
- 91
- Citations by year
- 2026: 11 · 2025: 18 · 2024: 13 · 2023: 24 · 2022: 19 · 2021: 25 · 2020: 16 · 2019: 19 · 2018: 30 · 2017: 22 · 2016: 22 · 2015: 3
- FWCI
- 3.16
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Expert Opinion on Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (R01AG034248, AG034248)
- National Institute of Neurological Disorders and Stroke (R01NS049442, NS49442)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, animal models, transgenic mice, APP/PS1 double transgenic mice, amyloid-beta, tau protein, amyloid plaques, neurofibrillary tangles, presenilin 1, amyloid precursor protein, physiological aging, drug discovery, preclinical testing
- MeSH terms
- Aging, Alzheimer Disease, Animals, Disease Models, Animal, Drug Evaluation, Preclinical, Humans, Mice, Transgenic, Rodentia, Species Specificity, Mice, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
